WESPAC Advisors’s Xylem XYL Stock Holding History

WESPAC Advisors’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-8,965	Closed	-$444K	–	132
2016 Q4	$444K	Sell	8,965 -1,098	-11%	-$55.7K	0.5%	61
2016 Q3	$528K	Buy	+10,063	New	+$493K	0.6%	60

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WESPAC Advisors's XYL Position: Q1 2017 in Review

WESPAC Advisors sold out of Xylem (XYL) in Q1 2017, closing a stake of 8,965 shares — an estimated $444K sold.

WESPAC Advisors first reported a position in XYL in Q3 2016 and held it in 2 quarters. The position peaked at $528K in Q3 2016. 546 funds tracked by Wall St. Rank hold XYL as of Q1 2017.

WESPAC Advisors reported no remaining Xylem position as of Q1 2017 after selling out during the quarter.
WESPAC Advisors sold 8,965 Xylem shares in Q1 2017, an estimated $444K.
WESPAC Advisors first reported a position in Xylem in Q3 2016 and held it in 2 quarters.
WESPAC Advisors's Xylem position peaked at $528K in Q3 2016.
546 funds tracked by Wall St. Rank held Xylem as of Q1 2017.

Based on WESPAC Advisors's 13F filing for Q1 2017, filed 8 May 2017.